1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Dexlansoprazole
Trade Name:
Dexilant
Manufacturer/Distributor:
Takeda
1-888-825-3321, option 3
www.takedacanada.com
Classification:
Proton pump inhibitor
ATC Class:
A02BC--
Status:
active
Notice of Compliance (yyyy/mm/dd):
2010/07/22
Date Marketed in Canada (yyyy/mm/dd):
2010/07/26
Presentation:
Capsule, delayed release: 30 mg DIN: 02354950
Capsule, delayed release: 60 mg DIN: 02354969
Comments:
For healing of all grades of erosive esophagitis; for maintaining healing of erosive esophagitis; for treatment of heartburn associated with non-erosive GERD. The capsule has a dual delayed release formulation and contains two types of enteric-coated granules with different pH-dependent dissolution profiles. One type of granule releases dexlansoprazole in the proximal small intestine; the other releases the drug in the distal region of the small intestine several hours later.
Back to:
Drug Product Listings 
